These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33858727)

  • 1. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update.
    Chen S; Chun KRJ; Ling Z; Liu S; Zhu L; Wang J; Schratter A; Acou WJ; Kiuchi MG; Yin Y; Schmidt B
    J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34208117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation.
    Noseworthy PA; Van Houten HK; Krumholz HM; Kent DM; Abraham NS; Graff-Radford J; Alkhouli M; Henk HJ; Shah ND; Gersh BJ; Friedman PA; Holmes DR; Yao X
    J Am Heart Assoc; 2022 Oct; 11(19):e027001. PubMed ID: 36172961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year Survival.
    Tiosano S; Banai A; Mulla W; Goldenberg I; Bayshtok G; Amit U; Shlomo N; Nof E; Rosso R; Glikson M; Guetta V; Barbash I; Beinart R
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    Kook H; Kim HD; Shim J; Kim YH; Kim JS; Pak HN; Lee HJ; Choi RK; Kang WC; Shin ES; Park JW; Yu CW; Lim DS
    PLoS One; 2021; 16(1):e0244723. PubMed ID: 33411816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Left Atrial Appendage Occlusion Versus Switch of Direct Oral Antcoagulant in Atrial Fibrillation: A Territory-Wide Retrospective Analysis.
    Ng AK; Ng PY; Ip A; Fung RC; Chui SF; Siu CW; Yan BP
    J Am Heart Assoc; 2023 Oct; 12(20):e029421. PubMed ID: 37804191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
    Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
    EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registry.
    Maarse M; Aarnink EW; Huijboom MFM; Abeln BGS; Staal D; Rensing BJWM; Kerklaan JP; van Dijk VF; Swaans MJ; Boersma LVA
    Heart Rhythm O2; 2023 May; 4(5):298-308. PubMed ID: 37323993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
    Yao X; Gersh BJ; Holmes DR; Melduni RM; Johnsrud DO; Sangaralingham LR; Shah ND; Noseworthy PA
    JAMA; 2018 May; 319(20):2116-2126. PubMed ID: 29800182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study).
    Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X
    J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation.
    Maille B; Defaye P; Bentounes SA; Herbert J; Clerc JM; Pierre B; Torras O; Deharo JC; Fauchier L
    Mayo Clin Proc; 2024 May; 99(5):754-765. PubMed ID: 38180394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation.
    Lee OH; Kim YD; Kim JS; Son NH; Pak HN; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jung YH; Choi HY; Lee KY; Cho BH; Han SW; Park JH; Cho HJ; Park HJ; Nam HS; Heo JH; So CY; Cheung GSH; Lam YY; Freixa X; Tzikas A; Jang Y; Park JW
    Korean Circ J; 2021 Jul; 51(7):626-638. PubMed ID: 34227275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
    Besola L; Gregori D; Fiocco A; Colli A
    Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
    Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.